Skip to main content
ConductScienceScienceDex

Samuel G Katz

NIH Rank #3370
Unclaimed recordClaim profile
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10234038Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology

NIH Funding · FY2024

Linked Award Amount
$2.6M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#3,370
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Samuel G Katz. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Samuel G Katz as a PI. Multi-PI records show the full award amount for context.

  • 1RF1NS126251-01A1RF1
    Cell Death Regulation by Pro-Apoptotic BOK in Tauopathies
    Yale University
    $2M
    award amount
  • 1R03AG087416-01R03
    Contribution of Mitochondrial Associated Membrane (MAM) Signaling to Neurodegeneration
    Yale University
    $335K
    award amount
  • 5R21CA282629-02R21
    Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell Reprogramming
    Yale University
    $186K
    award amount
  • 3R21CA282629-02S1R21
    Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell Reprogramming
    Yale University
    $84.6K
    award amount
  • 3R21CA282629-01S1R21
    Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell Reprogramming
    Yale University
    $33K
    award amount

Award organization

Organizations that administered FY2024 awards listing Samuel G Katz as a PI.

FY2024 award administered by Yale University (CT).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Yale University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3370
  6. 2024
    Entered Top 25% Nationally
    Ranked #3370

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Samuel G Katz.

Michael E Hurwitz
Yale University
3
shared awards

Explore further

Find collaborators for Samuel G Katz

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →